PLAZZI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 20.886
AS - Asia 13.826
EU - Europa 12.734
SA - Sud America 967
AF - Africa 872
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 12
Totale 49.332
Nazione #
US - Stati Uniti d'America 20.689
CN - Cina 4.060
SG - Singapore 3.995
GB - Regno Unito 3.536
VN - Vietnam 2.905
DE - Germania 2.018
IT - Italia 1.860
SE - Svezia 1.194
HK - Hong Kong 1.128
UA - Ucraina 902
IN - India 800
RU - Federazione Russa 790
BR - Brasile 740
FR - Francia 603
IE - Irlanda 523
KR - Corea 345
ZA - Sudafrica 300
EE - Estonia 257
NL - Olanda 219
JP - Giappone 205
TG - Togo 201
CI - Costa d'Avorio 192
CH - Svizzera 168
FI - Finlandia 141
SC - Seychelles 135
CA - Canada 108
BG - Bulgaria 104
AR - Argentina 100
BE - Belgio 96
JO - Giordania 82
ID - Indonesia 77
MX - Messico 67
AT - Austria 58
PL - Polonia 57
GR - Grecia 49
EC - Ecuador 43
ES - Italia 37
IR - Iran 36
AU - Australia 28
BD - Bangladesh 25
UZ - Uzbekistan 25
RS - Serbia 23
TR - Turchia 23
LB - Libano 22
CL - Cile 20
LT - Lituania 20
CO - Colombia 19
RO - Romania 19
IQ - Iraq 16
NG - Nigeria 14
PE - Perù 13
PY - Paraguay 12
DO - Repubblica Dominicana 11
AE - Emirati Arabi Uniti 10
DK - Danimarca 10
VE - Venezuela 10
A2 - ???statistics.table.value.countryCode.A2??? 9
IL - Israele 9
MY - Malesia 9
PK - Pakistan 9
KZ - Kazakistan 7
PT - Portogallo 7
SA - Arabia Saudita 7
UY - Uruguay 7
CZ - Repubblica Ceca 6
MA - Marocco 6
NZ - Nuova Zelanda 6
PH - Filippine 6
EG - Egitto 5
HR - Croazia 5
LU - Lussemburgo 5
NO - Norvegia 5
AL - Albania 4
KE - Kenya 4
MU - Mauritius 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
TN - Tunisia 4
AM - Armenia 3
AZ - Azerbaigian 3
MD - Moldavia 3
SM - San Marino 3
BO - Bolivia 2
CR - Costa Rica 2
DM - Dominica 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
ME - Montenegro 2
MN - Mongolia 2
TL - Timor Orientale 2
TT - Trinidad e Tobago 2
BY - Bielorussia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
Totale 49.316
Città #
Southend 3.073
Singapore 2.792
Fairfield 2.765
Ashburn 2.007
Chandler 1.342
Woodbridge 1.251
Houston 1.141
Seattle 1.123
Hong Kong 1.121
Wilmington 1.058
Cambridge 975
Ann Arbor 955
Hefei 930
Dong Ket 814
Santa Clara 763
Princeton 749
Jacksonville 546
Dublin 522
Beijing 503
Ho Chi Minh City 483
Boardman 475
Bologna 437
Seoul 343
Westminster 337
Hanoi 320
Nanjing 294
Padova 288
Los Angeles 287
Berlin 255
Lomé 201
Abidjan 192
Tokyo 191
New York 188
Saint Petersburg 167
Buffalo 166
Jinan 166
Redmond 159
San Diego 151
Shenyang 141
Redondo Beach 137
Bern 123
Turin 123
Dallas 112
Hebei 109
Mülheim 104
Changsha 103
Sofia 103
Milan 102
Helsinki 99
Nanchang 95
Frankfurt am Main 90
Brussels 89
Tianjin 88
Bengaluru 87
Amman 82
Medford 82
São Paulo 82
Redwood City 79
Dearborn 78
Des Moines 68
Chengdu 64
Falls Church 63
Guangzhou 62
Mahé 58
Munich 57
Rome 57
Shanghai 55
Phoenix 54
Yubileyny 54
Haiphong 52
Braunschweig 51
Chicago 49
Toronto 49
Jiaxing 48
Zhengzhou 48
Da Nang 44
London 42
Verona 42
Jakarta 41
Hangzhou 40
Norwalk 39
Florence 37
Biên Hòa 36
Falkenstein 36
Haikou 36
Kunming 35
Ningbo 35
San Francisco 34
Taizhou 34
Hải Dương 33
Olalla 32
Rio de Janeiro 32
Brooklyn 31
Kiev 30
Vienna 30
Boston 29
Lanzhou 28
Bühl 27
Atlanta 26
Taiyuan 26
Totale 33.382
Nome #
Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1 374
Actigraphic assessment of sleep/wake behavior in central disorders of hypersomnolence. 253
A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder. 235
Abnormal medial thalamic metabolism in patients with idiopathic restless legs syndrome. 232
Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy 230
Status dissociatus after surgery for tegmental ponto-mesencephalic cavernoma: a state-dependent disorder of motor control during sleep. 226
DNMT1 mutations leading to neurodegeneration paradoxically reflect on mitochondrial metabolism 222
Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation. 221
Behavioural and neurophysiological correlates of human cataplexy: a video-polygraphic study. 217
Abnormal sleep-cardiovascular system interaction in narcolepsy with cataplexy: effects of hypocretin deficiency in humans. 211
Automatic detection of cataplexy 211
Artificial protein and its applications 209
Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy. 206
Can smartphone sleep applications reliably assess sleep-wake cycle? Preliminary findings from a PSG study. 206
Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases 204
Sexsomnia: a diagnostic challenge, a case report 203
Intermittent head drops: the differential spectrum 200
Age-related differences in sleep-dependent consolidation of motor skills in patients with narcolepsy type 1 200
Childhood narcolepsy with cataplexy: comparison between post-H1N1 vaccination and sporadic cases. 196
Attention impairments and ADHD symptoms in adult narcoleptic patients with and without hypocretin deficiency 194
Biomarkers for REM sleep behavior disorder in idiopathic and narcoleptic patients 191
Cardiovascular autonomic dysfunction, altered sleep architecture, and muscle overactivity during nocturnal sleep in pediatric patients with narcolepsy type 1 190
Idiopathic recurrent stupor: Munchausen by proxy and medical litigation. 189
Excessive daytime sleepiness and subjective sleep quality in patients with nocturnal frontal lobe epilepsy: a case-control study. 189
Nocturnal Sleep Dynamics Identify Narcolepsy Type 1. 186
Catathrenia (nocturnal groaning): an abnormal respiratory pattern during sleep. 185
Memoria semantica durante il sonno REM di pazienti narcolettici 184
A quantitative statistical analysis of the submentalis muscle EMG amplitude during sleep in normal controls and patients with REM sleep behavior disorder. 184
Diagnostic accuracy of a structured interview for nocturnal frontal lobe epilepsy (SINFLE): a proposal for developing diagnostic criteria. 181
Body mass index-independent metabolic alterations in narcolepsy with cataplexy. 181
Antibodies against hypocretin receptor 2 are rare in narcolepsy 181
Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease 180
Autonomic disturbances in narcolepsy. 179
Mitochondrial abnormalities in fibroblasts carrying DNMT1 mutations 178
Augmentation of restless legs syndrome with long-term tramadol treatment. 177
Sleeping with spinal cord injury. 176
A quantitative analysis of the submentalis muscle electromyographic amplitude during rapid eye movement sleep across the lifespan. 176
The clinical spectrum of childhood narcolepsy 176
Incidence of sudden unexpected death in nocturnal frontal lobe epilepsy: a cohort study. 176
Propriospinal myoclonus: A motor phenomenon found in restless legs syndrome different from periodic limb movements during sleep. 175
Movement disorders in sleep: guidelines for differentiating epileptic from non-epileptic motor phenomena arising from sleep. 175
Catathrenia under sodium oxybate in narcolepsy with cataplexy. 175
Response to the letter "New avenues to prevent sudden unexpected death in nocturnal frontal lobe epilepsy: follow the route established by omega-3 polyunsaturated fatty acids". 174
High pain frequency in narcolepsy with cataplexy 174
A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy. 173
Common variants in P2RY11 are associated with narcolepsy 173
Catathrenia (sleep related groaning) 173
Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders. 171
Agrypnia Excitata: a microneurographic study of muscle sympathetic nerve activity. 171
Medico-legal assessment of disability in narcolepsy: an interobserver reliability study 171
(Not so) Smart sleep tracking through the phone: Findings from a polysomnography study testing the reliability of four sleep applications 170
The burden of narcolepsy with cataplexy: How disease history and clinical features influence socio-economic outcomes. 170
Eating disorders in narcolepsy type 1: Evidence from a cross-sectional Italian study 169
Sleep disorders in multiple system atrophy: a correlative video-polysomnographic study. 169
Cardiovascular variability as a function of sleep-wake behaviour in narcolepsy with cataplexy. 169
Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. 168
Response to "Dante's syncopes". 168
Cataplectic attacks during rapid eye movement sleep behavior disorder episodes in a narcoleptic patient. 168
Autism Spectrum Disorder and Narcolepsy: A Possible Connection That Deserves to Be Investigated. 168
Challenges in diagnosing narcolepsy without cataplexy: a consensus statement. 167
HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. 165
Clinical and polysomnographic course of childhood narcolepsy with cataplexy. 165
Car Crashes and Central Disorders of Hypersomnolence: A French Study. 165
Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. 164
Periodic leg movements during sleep in narcoleptic patients with or without restless legs syndrome. 163
Combined brain voxel-based morphometry and diffusion tensor imaging study in idiopathic Restless Legs Syndrome patients. 161
Cataplexy and ataxia: red flags for the diagnosis of DNA methyltransferase 1 mutation 161
Cognitive dysfunction in central disorders of hypersomnolence: A systematic review 161
Increased interferon-mediated immunity following in vitro and in vivo Modafinil treatment on peripheral immune cells 159
Motor events during REM sleep in patients with narcolepsy-cataplexy: a video-polysomnographic pilot study. 158
Semantic memory during REM sleep of narcoleptic patients 157
Detection of sleep onset by analysis of slow eye movements: A preliminary study of MSLT recordings. 157
Continuous motor unit activity syndromes: A video-polysomnographic study. 156
Cardiovascular reflexes in patients with recent onset hypertension. 156
Treatment of narcolepsy with cataplexy. 155
Olfactory dysfunction in narcolepsy with cataplexy. 155
Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus 155
World Association of Sleep Medicine (WASM) 2016 standards for recording and scoring leg movements in polysomnograms developed by a joint task force from the International and the European Restless Legs Syndrome Study Groups (IRLSSG and EURLSSG) 155
Story-like organization of REM-dreams in patients with narcolepsy-cataplexy. 154
Status dissociatus evolving from REM sleep behaviour disorder in multiple system atrophy. 154
New approaches to the study of periodic leg movements during sleep in restless legs syndrome. 154
Clinical Characteristics and Burden of Illness in Pediatric Patients with Narcolepsy 154
All-night EEG power spectral analysis of the cyclic alternating pattern components in young adult subjects. 153
Caratteristiche strutturali della attività mentali elaborate durante il sonno REM nei pazienti narcolettici 153
Impact of acute administration of sodium oxybate on nocturnal sleep polysomnography and on multiple sleep latency test in narcolepsy with cataplexy. 152
Narcolepsy is strongly associated with the T-cell receptor alpha locus. 152
Rhythmic movements and sleep paralysis in narcolepsy with cataplexy: a video-polygraphic study. 152
Las Parasomnias 152
In-field assessment of sodium oxybate effect in pediatric type 1 narcolepsy: An actigraphic study 152
Type 1 narcolepsy in anti-Hu antibodies mediated encephalitis: a case report 152
Narcolepsy features in young patients 151
Association of restless legs syndrome with nocturnal eating: a case-control study. 151
REM-dreams recall in patients with narcolepsy-cataplexy. 151
DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. 150
Sleep wake-and body core temperature cycles in patients with multiple sclerosis and fatigue. 150
Impact of COVID-19 pandemic lockdown on narcolepsy type 1 management 150
MR spectroscopy study of hypothalamic metabolism in narcolepsy and cluster headache. 149
INTRAVENOUS HIGH-DOSE IMMUNOGLOBULIN TREATMENT IN RECENT ONSET CHILDHOOD NARCOLEPSY WITH CATAPLEXY 149
Narcolepsy is a common phenotype in HSAN IE and ADCA-DN 149
Segmental hair testing of triazolam to unmask a suspected case of idiopathic recurrent Stupor 149
Totale 17.701
Categoria #
all - tutte 140.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.428


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.632 0 0 0 0 0 258 198 399 462 294 262 1.759
2021/20226.406 682 248 482 356 637 356 192 486 351 447 1.119 1.050
2022/20236.023 657 865 318 753 371 446 171 322 1.031 259 505 325
2023/20241.850 133 322 145 230 125 351 107 97 45 130 80 85
2024/20257.115 235 1.255 582 538 1.275 382 416 153 83 323 342 1.531
2025/20269.169 1.675 2.091 1.805 1.478 1.954 166 0 0 0 0 0 0
Totale 50.175